secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0001213900-23-014316
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma Holdings announces 1-for-10 reverse stock split effective March 6, 2023
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-10 ratio, effective March 6, 2023, trading begins on split-adjusted basis at market open.
- Every 10 existing shares convert into 1 share; fractional shares rounded up to whole number.
- Approved by Board and stockholders at Annual Meeting on December 27, 2022.
- Trading symbol remains 'CPHI' on NYSE American; new CUSIP number 16941T-203.
- Reverse stock split does not alter any stockholder's percentage interest except for fractional share adjustments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390023014316/0001213900-23-014316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390023014316/ea174228-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-014316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer